D
Arcellx, Inc. ACLX
$87.50 $1.471.71% NASDAQ
Recommendation
Prev Close
$86.03
Volume
11
Avg Vol (90D)
515,785
Market Cap
$4.77B
Dividend & Yield
--
52-Week Range
$47.86 - $107.37
P/E (TTM)
--
EPS (TTM)
-$3.42
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Arcellx (ACLX) Projected to Post Quarterly Earnings on Thursday
10/31/2025 - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
10/31/2025 - MarketBeat
Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
10/30/2025 - Zacks Investment Research
A Fresh Look at Arcellx (ACLX) Valuation Following Analyst Confidence in Clinical Progress
10/29/2025 - Simply Wall St
Arcellx management to meet with Piper Sandler
10/28/2025 - The Fly
Arcellx (ACLX, $86.7) entered Uptrend as Momentum indicator ascends above 0 level on Oct 27, 2025
10/28/2025 - Tickeron - Stocks
Arcellx (ACLX, $86.7) Aroon Indicator entered an Uptrend on October 27, 2025.
10/28/2025 - Tickeron - Stocks
Arcellx Advances in Autoimmune Treatment with Anitocabtagene Autoleucel Study
10/27/2025 - TipRanks Financial Blog
Weiss Ratings Reaffirms Sell (D-) Rating for Arcellx (NASDAQ:ACLX)
10/25/2025 - MarketBeat
Arcellx (ACLX, $84.68) Aroon Indicator entered an Uptrend on October 24, 2025.
10/25/2025 - Tickeron - Stocks
Arcellx, Inc. $ACLX Shares Sold by Sector Gamma AS
10/24/2025 - MarketBeat
Arcellx (ACLX, $84.07) Aroon Indicator entered an Uptrend on October 23, 2025.
10/24/2025 - Tickeron - Stocks
Arcellx (ACLX, $83.36) Aroon Indicator entered an Uptrend on October 22, 2025.
10/23/2025 - Tickeron - Stocks
Arcellx (ACLX, $85.62) Aroon Indicator entered an Uptrend on October 21, 2025.
10/22/2025 - Tickeron - Stocks
Arcellx (ACLX, $86.77) Aroon Indicator entered an Uptrend on October 20, 2025.
10/21/2025 - Tickeron - Stocks
Arcellx, Inc. $ACLX Shares Sold by TD Asset Management Inc
10/20/2025 - MarketBeat
Arcellx (ACLX, $86.99) Aroon Indicator entered an Uptrend on October 17, 2025.
10/18/2025 - Tickeron - Technical Analysis
Leerink Partners Keeps Their Buy Rating on Arcellx Inc (ACLX)
10/17/2025 - TipRanks Financial Blog
Arcellx (ACLX, $88.85) RSI Indicator left the overbought zone on October 16, 2025
10/17/2025 - Tickeron - Stocks
Arcellx (ACLX, $88.85) Aroon Indicator entered an Uptrend on October 16, 2025.
10/17/2025 - Tickeron - Stocks
Stifel Reinstates Buy Rating for Arcellx (ACLX) with $129 Target ACLX Stock News
10/16/2025 - GuruFocus
Arcellx (ACLX): Analyst Predicts Strong Future for CAR T Therapy
10/16/2025 - GuruFocus
Arcellx resumed with a Buy at Stifel
10/16/2025 - The Fly
Arcellx (ACLX, $92.37) Aroon Indicator entered an Uptrend on October 15, 2025.
10/16/2025 - Tickeron - Stocks
Insider Sell: Michelle Gilson Sells 5,364 Shares of Arcellx Inc (ACLX)
10/16/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$56.98M
EBITDA (TTM)
-$208.08M
EBIT (TTM)
-$214.39M
Net Income (TTM)
-$187.99M
Balance Sheet
Total Assets (Q)
$619.09M
Total Debt (Q)
$52.51M
Total Liabilities (Q)
$226.86M
Book Value Per Share (Q)
$7.08
Cash Flow
Cash from Operations (TTM)
-$118.19M
Cash from Investing (TTM)
$80.17M
Cash from Financing (TTM)
$125.00K
Net Change in Cash (TTM)
-$37.90M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
1.85
7-Day Total Return
2.20%
30-Day Total Return
9.40%
60-Day Total Return
23.81%
90-Day Total Return
38.12%
Year to Date Total Return
11.11%
1-Year Total Return
0.79%
2-Year Total Return
156.30%
3-Year Total Return
272.66%
5-Year Total Return
--
52-week Low
May 07, 2025 - $47.86
52-week High
Nov 12, 2024 - $107.37
Valuation
Market Cap
$4.77B - Mid Cap
Enterprise Value
$4.29B
Price/Sales (TTM)
84.89
Price/Book (Q)
12.15
Dividends and Shares
Shares Outstanding
56.22
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arcellx.com
Phone Number
240 327 0630
Address
800 Bridge Parkway
Redwood City, CA 94065
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company’s lead... more
NASDAQ 10/30/2025 4:00PM Eastern Quotes delayed